首页|Manufacturing of biomedical Ti alloys with controlled oxygen content by blended elemental powder metallurgy
Manufacturing of biomedical Ti alloys with controlled oxygen content by blended elemental powder metallurgy
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NSTL
Elsevier
? 2022 Elsevier B.V.Biomedical Ti-xNb-7Zr-0.7O (wt%) alloys were manufactured from elemental powders and controlled addition of TiO2 using field assisted sintering technique (FAST). First, sintering parameters were optimized on the benchmark Ti-29Nb-7Zr-0.7O alloy. Second, alloys with various content of Nb (20, 23, 26 and 29 wt%) were manufactured. FAST is capable to produce homogeneous material with controlled amount of oxygen. In addition, FAST is a valuable method for fast sampling of alloys with different compositions. Detailed XRD and SEM study proved that oxygen prevents formation of α” martensite phase. Presence of α phase, α” phase and especially ω phase causes an increase of elastic modulus and microhardness. Single phase β Ti-29Nb-7Zr-0.7O alloy can be manufactured by FAST from elemental powders and subsequent solution treatment. The alloy is proposed for biomedical use due to its low elastic modulus.